# Oxytocin Treatment for Alcohol Use Disorders

> **NCT03636555** · PHASE2 · WITHDRAWN · sponsor: **University of North Carolina, Chapel Hill**

## Conditions studied

- Alcohol Use Disorder

## Interventions

- **DRUG:** Oxytocin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03636555
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-10
- **Primary completion:** 2022-09
- **Final completion:** 2022-09
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** PI no longer employed at Institution
- **Last updated:** 2019-11-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03636555

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03636555, "Oxytocin Treatment for Alcohol Use Disorders". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT03636555. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*